Definitive Healthcare Corp. named Clay Ritchey as its new chief executive officer, effective September 8, 2026, following the departure of Kevin Coop, who stepped down from the role and board on August 31, 2026 after serving as CEO since June 2024.
Ritchey brings more than 25 years of experience in healthcare master data and technology markets, including leadership roles at Verato, Evariant (acquired by Healthgrades), Imprivata, and Equinox Healthcare. Prior to those positions, he held senior marketing roles at Hill-Rom and Kronos, according to the company’s announcement.
Definitive Healthcare, based in Framingham, Massachusetts, provides proprietary datasets and analytics to healthcare organizations and companies, focusing on business-side insights. The leadership transition coincides with the company’s development of an AI-powered platform that integrates healthcare data with conversational AI and workflow automation.
Jason Krantz, chairman of Definitive Healthcare’s board, said the appointment reflects the company’s commitment to growth and innovation in a large, attractive market. Ritchey highlighted the company’s proprietary datasets and expanding solution portfolio as key differentiators in addressing customer challenges.
The NASDAQ-listed firm did not disclose additional financial or operational details regarding the transition.
